TrimRx
San Diego-based GLP-1 weight loss telehealth offering compounded semaglutide and tirzepatide at $179-349/month with LegitScript dual certification.
What we like
What to watch
Full Review
TrimRx has captured meaningful volume in the crowded compounded GLP-1 telehealth space since its June 2024 launch, claiming over 300,000 patients served — though this figure warrants skepticism given the company's sub-$300K monthly revenue profile. The dual LegitScript certification and absence from the FDA's 2025 enforcement wave are genuine differentiators, and offering oral/sublingual formats alongside injectables provides a modest competitive edge. However, the company faces material customer service and retention risks, with persistent BBB complaints about cancellation friction and a strict refund policy. At current pricing TrimRx is competitive but not the cheapest; the real question is whether support infrastructure can match patient acquisition pace.
Last researched: 2026-03-30
Pricing
| Treatment | Category | Price/mo | Includes | Notes |
|---|---|---|---|---|
| Compounded Semaglutide (Injectable) | Weight Loss / GLP-1 | $199 | ● Consults○ Lab work● Shipping | Subscription required |
| Compounded Semaglutide (Oral/Sublingual) | Weight Loss / GLP-1 | $179 | ● Consults○ Lab work● Shipping | Subscription required |
| Compounded Tirzepatide (Injectable) | Weight Loss / GLP-1 | $349 | ● Consults○ Lab work● Shipping | $199 first month for qualifying patients Subscription required |